Repository logo
 
Publication

Paper 2: EUROCAT public health indicators for congenital anomalies in Europe

dc.contributor.authorKhoshnood, Babak
dc.contributor.authorGreenlees, Ruth
dc.contributor.authorLoane, Maria
dc.contributor.authorDolk, Helen
dc.contributor.authorEUROCAT Project Management Committee
dc.contributor.authorEUROCAT Working Group
dc.date.accessioned2012-02-15T18:40:09Z
dc.date.available2012-02-15T18:40:09Z
dc.date.issued2011-03-04
dc.descriptionEUROCAT Working group collaborator: Carlos Matias Diaspor
dc.description.abstractThe purpose of this article is to present the specific public health indicators recently developed by EUROCAT that aim to summarize important aspects of the public health impact of congenital anomalies in a few quantitative measures. METHODS: The six indicators are: (1) congenital anomaly perinatal mortality, (2) congenital anomaly prenatal diagnosis prevalence, (3) congenital anomaly termination of pregnancy, (4) Down syndrome livebirth prevalence, (5) congenital anomaly pediatric surgery, and (6) neural tube defects (NTD) total prevalence. Data presented for this report pertained to all cases (livebirths, fetal deaths, or stillbirths after 20 weeks of gestation and terminations of pregnancy for fetal anomaly [TOPFA]) of congenital anomaly from 27 full member registries of EUROCAT that could provide data for at least 3 years during the period 2004 to 2008. Prevalence of anomalies, prenatal diagnosis, TOPFA, pediatric surgery, and perinatal mortality were calculated per 1000 births. RESULTS: The overall perinatal mortality was approximately 1.0 per 1000 births for EUROCAT registries with almost half due to fetal and the other half due to first week deaths. There were wide variations in perinatal mortality across the registries with the highest rates observed in Dublin and Malta, registries in countries where TOPFA are illegal, and in Ukraine. The overall perinatal mortality across EUROCAT registries slightly decreased between 2004 and 2008 due to a decrease in first week deaths. The prevalence of TOPFA was fairly stable at about 4 per 1000 births. There were variations in livebirth prevalence of cases typically requiring surgery across the registries; however, for most registries this prevalence was between 3 and 5 per 1000 births. Prevalence of NTD decreased by about 10% from 1.05 in 2004 to 0.94 per 1000 in 2008. CONCLUSION: It is hoped that by publishing the data on EUROCAT indicators, the public health importance of congenital anomalies can be clearly summarized to policy makers, the need for accurate data from registries emphasized, the need for primary prevention and treatment services highlighted, and the impact of current services measured.por
dc.identifier.citationBirth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S16-22. doi: 10.1002/bdra.20776. Epub 2011 Mar 4por
dc.identifier.issn1542-0752
dc.identifier.otherdoi:10.1002/bdra.20776
dc.identifier.urihttp://hdl.handle.net/10400.18/586
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherWiley-Blackwell - Wiley-Lisspor
dc.relation.publisherversionhttp://onlinelibrary.wiley.com/doi/10.1002/bdra.20776/pdfpor
dc.subjectCongenital Anomaliespor
dc.subjectPublic Hpor
dc.subjectIndicatorspor
dc.subjectPrenatal Diagnosispor
dc.subjectPerinatal Mortalitypor
dc.subjectEstados de Saúde e de Doençapor
dc.subjectRENACpor
dc.titlePaper 2: EUROCAT public health indicators for congenital anomalies in Europepor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPageS22por
oaire.citation.startPageS16por
oaire.citation.titleBirth Defects Research Part A: Clinical and Molecular Teratologypor
rcaap.rightsrestrictedAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Paper 2 - EUROCAT public health indicators for congenital anomalies in Europe.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: